Category - Executive Moves

Executive Moves

Tom Tamberrino joins Profound as new CCO ahead of TULSA reimbursement going into effect at the start of 2025

Profound Medical (NASDAQ:PROF; TSX:PRN) announced the appointment of Tom Tamberrino as chief commercial officer (CCO). Abbey Goodman, the current CCO, will now lead strategic partnerships and continue to report to CEO...

October 17, 2024

Executive Moves

Lake Street Captial Markets names Alex Nowak as director investment banking

Alex Nowak has joined Lake Street Capital Markets’ growing banking team as director of the healthcare investment banking practice. In his new role, Mr. Nowak will focus on expanding client relationships and supporting...

October 15, 2024

Executive Moves

Murat Omur joins Ladenburg Thalmann as managing director in healthcare IB

Ladenburg Thalmann has announced the appointment of Murat Omur as managing director in the healthcare investment banking division. With 17 years of investment banking experience in healthcare and the M&A sector, Mr...

October 15, 2024

Executive Moves

MaxCyte appoints Ali Soleymannezhad as CCO

MaxCyte (NASDAQ:MXCT; LSE:MXCT) has appointed Ali Soleymannezhad as chief commercial officer, effective September 11, 2024. Prior to this role, Mr. Soleymannezhad served as executive vice president of bioprocessing at...

October 10, 2024

Executive Moves

Sernova appoints David Patterson Ph.D. to BOD

Sernova Corp. (TSX:SVA) has announced the appointment of David Patterson, Ph.D., to its board of directors, effective immediately. “I am pleased to have been able to attract David Paterson’s significant talent to...

September 19, 2024

Executive Moves

Therma Bright adds pharma veteran Douglas S. Sommerville to AB

Therma Bright (TSXV: THRM; OTCQB: TBRIF), has announced the addition of Douglas S. Sommerville to its advisory board. In a statement, Rob Fia, CEO of Therma Bright, said, “Doug is highly respected across North...

September 12, 2024

Executive Moves

Creyon Bio appoints venture capitalists Serge Messerlian and Shaquille Vayda to board

Creyon Bio has appointed two prominent venture capitalists, Serge Messerlian, operating partner at DCVC Bio, and Shaquille Vayda, principal at Lux Capital, to its board. “We are excited to welcome Serge and Shaq...

September 10, 2024

Executive Moves

MOBILion appoints Rohit Khanna to BOD

Closely-held MOBILion Systems has announced the appointment of seasoned life sciences executive, Rohit Khanna, Ph.D., to its board, effective immediately. Dr. Khanna co-founded software engineering firm Dynamic...

August 28, 2024

Executive Moves

ANEW Medical appoints Jeffrey LeBlanc as CFO

ANEW Medical (NASDAQ:WENA) announced the appointment of Jeffrey LeBlanc as its new CFO, succeeding interim CFO, Edward Cong Wang, the former CFO of Redwoods Acquisition, which ANEW merged with. ANEW’s portfolio includes...

August 19, 2024

Executive Moves

Carisma Therapeutics expands SAB with renowned KOLs

Carisma Therapeutics (NASDAQ:CARM) has appointed Drs. Scott Friedman and Ira Tabas to its scientific advisory board (SAB). “It is an honor to welcome Dr. Friedman and Dr. Tabas to our SAB,” said Steven...

August 6, 2024

Category - Executive Moves

Tom Tamberrino joins Profound as new CCO ahead of TULSA reimbursement going into effect at the start of 2025

Lake Street Captial Markets names Alex Nowak as director investment banking

Murat Omur joins Ladenburg Thalmann as managing director in healthcare IB

MaxCyte appoints Ali Soleymannezhad as CCO

Sernova appoints David Patterson Ph.D. to BOD

Therma Bright adds pharma veteran Douglas S. Sommerville to AB

Creyon Bio appoints venture capitalists Serge Messerlian and Shaquille Vayda to board

MOBILion appoints Rohit Khanna to BOD

ANEW Medical appoints Jeffrey LeBlanc as CFO

Carisma Therapeutics expands SAB with renowned KOLs

General

More